A prospective clinical study shows that the GeneSearch Breast Lymph Node Assay, a gene-based diagnostic test, has greater sensitivity than traditional intra-operative methods of detecting the spread of breast cancer to the lymph nodes. In the study, sponsored by Veridex LLC, the GeneSearch demonstrated overall sensitivity at least 10 percentage points higher than intra-operative tests.

Quest Diagnostics Inc. has introduced its newly developed test, the Breast Cancer Gene Expression Ratio, to help ...

During last year's influenza season, the number of infants and toddlers in the U.S. who were vaccinated against the flu ...

A Navy plan to test a blood substitute on civilian trauma victims should remain on hold, federal health advisers ...

For the first time, the National Comprehensive Cancer Network has included hyperthermia therapy and radiation as ...

Patients with an intermediate likelihood of coronary artery disease can benefit from both multislice computed tomography ...

Trust for America's Health (TFAH) today released the fourth annual "Ready or Not? Protecting the Public's Health from ...

Breast cancer rates in the United States dropped dramatically in 2003, and experts attribute the sudden decline to the ...

A new study published in the December 2006 issue of Gastroenterology that investigated the effect of CAD on readers' ...

New research offers this warning to consumers shopping for top-notch hospitals: Many that are highly rated by government ...